サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701906

筋萎縮性側索硬化症（ALS）治療市場：ALSタイプ別、薬剤タイプ別、診断タイプ別、治療別、流通チャネル別、地域別、2025-2033年

Amyotrophic Lateral Sclerosis Treatment Market Report by ALS Type, Drug Type, Diagnosis Type, Treatment, Distribution Channel, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 140 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
筋萎縮性側索硬化症（ALS）治療市場：ALSタイプ別、薬剤タイプ別、診断タイプ別、治療別、流通チャネル別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

筋萎縮性側索硬化症（ALS）治療市場の世界市場規模は2024年に7億8,700万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに11億3,450万米ドルに達し、2025年から2033年にかけて4.15%の成長率（CAGR）を示すと予測しています。

筋萎縮性側索硬化症（ALS）治療とは、脊髄と脳の神経細胞が侵され、筋肉の制御ができなくなる変性疾患を指します。主に遺伝子の突然変異、免疫反応の乱れ、化学物質の不均衡などが原因で発症します。ALSの一般的な症状としては、筋肉のこわばり、筋肉のひきつり、脚や腕の脱力、認知や行動の変化、嚥下障害、ろれつが回らないなどがあります。ALSの診断は、病歴、身体所見、電気診断検査、神経画像検査によって行われます。

筋萎縮性側索硬化症（ALS）治療市場傾向：

筋萎縮性側索硬化症（ALS）治療市場を牽引しているのは、ライフスタイルの変化や多忙なスケジュールによる神経変性疾患の増加です。これに加えて、このような神経疾患に罹患しやすい老年人口の拡大もまた、市場の成長を増大させています。さらに、NGOや民間団体がALSの診断や治療に関する認知度を高めるために様々な取り組みを行っています。このことは、市場にとって明るい展望をもたらしています。さらに、ALSに対する標的治療や対症療法が浸透しつつあることも、市場の成長を促す大きな要因となっています。さらに、臨床試験への注目の高まりとALS治療用経口薬の早期承認も市場の成長を後押ししています。さらに、筋機能の強化、免疫調節、神経保護を目的とした革新的な治療法を開発するため、様々な研究機関との戦略的共同研究が増加していることも、世界市場をさらに活性化しています。今後数年間、改修政策の浸透とともにヘルスケアインフラの継続的なアップグレードが、世界の筋萎縮性側索硬化症（ALS）治療市場を引き続き牽引していくでしょう。

本レポートで扱う主な質問

  • 2024年の世界の筋萎縮性側索硬化症（ALS）治療市場の市場規模は？
  • 2025-2033年における世界の筋萎縮性側索硬化症（ALS）治療市場の予想成長率は？
  • 世界の筋萎縮性側索硬化症（ALS）治療市場を牽引する主要因は何か？
  • 世界の筋萎縮性側索硬化症（ALS）治療市場に対するCOVID-19の影響は？
  • 世界の筋萎縮性側索硬化症（ALS）治療市場の治療別の内訳は？
  • 世界の筋萎縮性側索硬化症（ALS）治療市場の流通チャネル別の内訳は？
  • 世界の筋萎縮性側索硬化症（ALS）治療市場の主要地域は？
  • 世界の筋萎縮性側索硬化症（ALS）治療市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の筋萎縮性側索硬化症（ALS）治療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：ALSタイプ別

  • 特発性ALS
  • 家族性ALS

第7章 市場内訳：薬剤タイプ別

  • 上市薬
  • 新興薬

第8章 市場内訳：診断タイプ別

  • 筋電図
  • MRI
  • 血液検査・尿検査
  • 脊髄穿刺
  • 筋生検

第9章 市場内訳：治療別

  • 投薬
  • 幹細胞療法
  • その他

第10章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • その他

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AB Science
    • Ascend Pharmaceuticals LLC
    • BrainStorm Cell Therapeutics Inc.
    • Corestem Inc.
    • Cytokinetics Inc.
    • Eledon Pharmaceuticals Inc.
    • Ionis Pharmaceuticals Inc.
    • ITF Pharma（Italfarmaco S.p.A）
    • Mitsubishi Chemical Group Corpotion
    • Revalesio Corporation
    • Treeway B.V.
図表

List of Figures

  • Figure 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by ALS Type (in %), 2024
  • Figure 5: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 6: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Diagnosis Type (in %), 2024
  • Figure 7: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Treatment (in %), 2024
  • Figure 8: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 9: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Amyotrophic Lateral Sclerosis Treatment (Sporadic ALS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Amyotrophic Lateral Sclerosis Treatment (Sporadic ALS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Amyotrophic Lateral Sclerosis Treatment (Familial ALS) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Amyotrophic Lateral Sclerosis Treatment (Familial ALS) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Amyotrophic Lateral Sclerosis Treatment (Marketed Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Amyotrophic Lateral Sclerosis Treatment (Marketed Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Amyotrophic Lateral Sclerosis Treatment (Emerging Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Amyotrophic Lateral Sclerosis Treatment (Emerging Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Amyotrophic Lateral Sclerosis Treatment (Electromyogram) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Amyotrophic Lateral Sclerosis Treatment (Electromyogram) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Amyotrophic Lateral Sclerosis Treatment (MRI) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Amyotrophic Lateral Sclerosis Treatment (MRI) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Amyotrophic Lateral Sclerosis Treatment (Blood and Urine Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Amyotrophic Lateral Sclerosis Treatment (Blood and Urine Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Amyotrophic Lateral Sclerosis Treatment (Spinal Tap) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Amyotrophic Lateral Sclerosis Treatment (Spinal Tap) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Amyotrophic Lateral Sclerosis Treatment (Muscle Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Amyotrophic Lateral Sclerosis Treatment (Muscle Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Amyotrophic Lateral Sclerosis Treatment Industry: SWOT Analysis
  • Figure 90: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by ALS Type (in Million USD), 2025-2033
  • Table 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 4: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Diagnosis Type (in Million USD), 2025-2033
  • Table 5: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Treatment (in Million USD), 2025-2033
  • Table 6: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 7: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Amyotrophic Lateral Sclerosis Treatment Market: Competitive Structure
  • Table 9: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Players
目次
Product Code: SR112025A6057

The global amyotrophic lateral sclerosis treatment market size reached USD 787.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,134.5 Million by 2033, exhibiting a growth rate (CAGR) of 4.15% during 2025-2033.

Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal cord and brain, resulting in loss of muscle control. It primarily occurs due to gene mutation, disorganized immune response, chemical imbalance, etc. Some of the common symptoms of ALS include muscle stiffness, twitching of the muscles, weakness in the legs or arms, cognitive and behavioral changes, trouble in swallowing, slurred speech, etc. The diagnosis of ALS relies on medical history, physical examination, electrodiagnostic testing, and neuroimaging.

Amyotrophic Lateral Sclerosis Treatment Market Trends:

The rising incidences of neurodegenerative disorders due to changing lifestyle patterns and hectic schedules of the individuals are primarily driving the Amyotrophic Lateral Sclerosis Treatment treatment market. Besides this, the expanding geriatric population, who are more susceptible to such neurological ailments, is also augmenting the market growth. Furthermore, several NGOs and private organizations are undertaking numerous initiatives to increase awareness regarding the diagnosis and treatment of ALS among the masses. This, in turn, is creating a positive outlook for the market. Additionally, the growing penetration of targeted and symptomatic treatment options for ALS is acting as a significant growth-inducing factor. Moreover, the elevating focus on clinical trials and faster approval of oral drugs for ALS treatment is also bolstering the market growth. Moreover, the increasing strategic collaborations among various research institutes to develop innovative treatment procedures that aim at enhancing muscle function, immune modulation, and neuroprotection are further catalyzing the global market. In the coming years, the continuous upgradation of healthcare infrastructures along with elevating penetration of refurbishment policies will continue to drive the global amyotrophic lateral sclerosis (ALS) treatment market.

Key Market Segmentation:

Breakup by ALS Type:

  • Sporadic ALS
  • Familial ALS

Breakup by Drug Type:

  • Marketed Drugs
  • Emerging Drugs

Breakup by Diagnosis Type:

  • Electromyogram
  • MRI
  • Blood and Urine Tests
  • Spinal Tap
  • Muscle Biopsy

Breakup by Treatment:

  • Medication
  • Stem Cell Therapy
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Ascend Pharmaceuticals LLC, BrainStorm Cell Therapeutics Inc., Corestem Inc., Cytokinetics Inc., Eledon Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., ITF Pharma (Italfarmaco S.p.A), Mitsubishi Chemical Group Corpotion, Revalesio Corporation and Treeway B.V.

Key Questions Answered in This Report

  • 1.What was the size of the global amyotrophic lateral sclerosis treatment market in 2024?
  • 2.What is the expected growth rate of the global amyotrophic lateral sclerosis treatment market during 2025-2033?
  • 3.What are the key factors driving the global amyotrophic lateral sclerosis treatment market?
  • 4.What has been the impact of COVID-19 on the global amyotrophic lateral sclerosis treatment market?
  • 5.What is the breakup of the global amyotrophic lateral sclerosis treatment market based on the treatment?
  • 6.What is the breakup of the global amyotrophic lateral sclerosis treatment market based on the distribution channel?
  • 7.What are the key regions in the global amyotrophic lateral sclerosis treatment market?
  • 8.Who are the key players/companies in the global amyotrophic lateral sclerosis treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Amyotrophic Lateral Sclerosis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by ALS Type

  • 6.1 Sporadic ALS
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Familial ALS
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Marketed Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Emerging Drugs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Diagnosis Type

  • 8.1 Electromyogram
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 MRI
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blood and Urine Tests
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Spinal Tap
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Muscle Biopsy
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Treatment

  • 9.1 Medication
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stem Cell Therapy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Retail Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AB Science
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Ascend Pharmaceuticals LLC
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 BrainStorm Cell Therapeutics Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Corestem Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 Cytokinetics Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Eledon Pharmaceuticals Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Ionis Pharmaceuticals Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 ITF Pharma (Italfarmaco S.p.A)
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Mitsubishi Chemical Group Corpotion
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Revalesio Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Treeway B.V.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio